Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy
ObjectiveTo assess the feasibility and safety of zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN) after preoperative superselective transarterial embolization (STE) of T1 renal cancer.MethodsWe retrospectively analyzed the data of 32 patients who underwent zero ischaemia RALP...
| Main Authors: | , , , , , , , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Frontiers Media S.A.
2023-08-01
|
| Series: | Frontiers in Oncology |
| Subjects: | |
| Online Access: | https://www.frontiersin.org/articles/10.3389/fonc.2023.1212696/full |
| _version_ | 1797739263531417600 |
|---|---|
| author | Haichang Li Yuning Hu Dongning Lu Jingyun Wang Yanze Lin Xugang Zhong Yixuan Mou Cenchao Yao Zhida Wang Xinyu Zhang Qijun Wo Hanbo Liu Feng Liu Dahong Zhang Heng Wang |
| author_facet | Haichang Li Yuning Hu Dongning Lu Jingyun Wang Yanze Lin Xugang Zhong Yixuan Mou Cenchao Yao Zhida Wang Xinyu Zhang Qijun Wo Hanbo Liu Feng Liu Dahong Zhang Heng Wang |
| author_sort | Haichang Li |
| collection | DOAJ |
| description | ObjectiveTo assess the feasibility and safety of zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN) after preoperative superselective transarterial embolization (STE) of T1 renal cancer.MethodsWe retrospectively analyzed the data of 32 patients who underwent zero ischaemia RALPN after STE and 140 patients who received standard robot-assisted laparoscopic partial nephrectomy (S-RALPN). In addition, we selected 35 patients treated with off-clamp RALPN (O-RALPN) from September 2017 to March 2022 for comparison. STE was performed by the same interventional practitioner, and zero ischaemia laparoscopic partial nephrectomy (LPN) was carried out by experienced surgeon 1-12 hours after STE. The intraoperative data and postoperative complications were recorded. The postoperative renal function, routine urine test, urinary Computed Tomography (CT), and preoperative and postoperative glomerular filtration rate (GFR) data were analyzed.ResultsAll operations were completed successfully. There were no cases of conversion to opening and no deaths. The renal arterial trunk was not blocked. No blood transfusions were needed. The mean operation time was 91.5 ± 34.28 minutes. The mean blood loss was 58.59 ± 54.11 ml. No recurrence or metastasis occurred.ConclusionFor patients with renal tumors, STE of renal tumors in zero ischaemia RALPN can preserve more renal function, and it provides a safe and feasible surgical method. |
| first_indexed | 2024-03-12T13:55:41Z |
| format | Article |
| id | doaj.art-3ab1a96f126240cea9e912eb08033592 |
| institution | Directory Open Access Journal |
| issn | 2234-943X |
| language | English |
| last_indexed | 2024-03-12T13:55:41Z |
| publishDate | 2023-08-01 |
| publisher | Frontiers Media S.A. |
| record_format | Article |
| series | Frontiers in Oncology |
| spelling | doaj.art-3ab1a96f126240cea9e912eb080335922023-08-22T15:21:16ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2023-08-011310.3389/fonc.2023.12126961212696Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomyHaichang Li0Yuning Hu1Dongning Lu2Jingyun Wang3Yanze Lin4Xugang Zhong5Yixuan Mou6Cenchao Yao7Zhida Wang8Xinyu Zhang9Qijun Wo10Hanbo Liu11Feng Liu12Dahong Zhang13Heng Wang14Urology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaCancer Center, Department of Interventional Medicine, Zhejiang Provincial People’s Hospital, Affiliated People’s Hospital, Hangzhou Medical College, Hangzhou, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaUrology & Nephrology Center, Department of Urology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital, Hangzhou Medical College), Hangzhou, Zhejiang, ChinaObjectiveTo assess the feasibility and safety of zero ischaemia robotic-assisted laparoscopic partial nephrectomy (RALPN) after preoperative superselective transarterial embolization (STE) of T1 renal cancer.MethodsWe retrospectively analyzed the data of 32 patients who underwent zero ischaemia RALPN after STE and 140 patients who received standard robot-assisted laparoscopic partial nephrectomy (S-RALPN). In addition, we selected 35 patients treated with off-clamp RALPN (O-RALPN) from September 2017 to March 2022 for comparison. STE was performed by the same interventional practitioner, and zero ischaemia laparoscopic partial nephrectomy (LPN) was carried out by experienced surgeon 1-12 hours after STE. The intraoperative data and postoperative complications were recorded. The postoperative renal function, routine urine test, urinary Computed Tomography (CT), and preoperative and postoperative glomerular filtration rate (GFR) data were analyzed.ResultsAll operations were completed successfully. There were no cases of conversion to opening and no deaths. The renal arterial trunk was not blocked. No blood transfusions were needed. The mean operation time was 91.5 ± 34.28 minutes. The mean blood loss was 58.59 ± 54.11 ml. No recurrence or metastasis occurred.ConclusionFor patients with renal tumors, STE of renal tumors in zero ischaemia RALPN can preserve more renal function, and it provides a safe and feasible surgical method.https://www.frontiersin.org/articles/10.3389/fonc.2023.1212696/fullsuperselective renal artery embolizationzero ischemiapartial nephrectomynephron-sparing surgery (NSS)robotic-assisted |
| spellingShingle | Haichang Li Yuning Hu Dongning Lu Jingyun Wang Yanze Lin Xugang Zhong Yixuan Mou Cenchao Yao Zhida Wang Xinyu Zhang Qijun Wo Hanbo Liu Feng Liu Dahong Zhang Heng Wang Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy Frontiers in Oncology superselective renal artery embolization zero ischemia partial nephrectomy nephron-sparing surgery (NSS) robotic-assisted |
| title | Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy |
| title_full | Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy |
| title_fullStr | Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy |
| title_full_unstemmed | Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy |
| title_short | Clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic-assisted laparoscopic partial nephrectomy |
| title_sort | clinical application of superselective transarterial embolization of renal tumors in zero ischaemia robotic assisted laparoscopic partial nephrectomy |
| topic | superselective renal artery embolization zero ischemia partial nephrectomy nephron-sparing surgery (NSS) robotic-assisted |
| url | https://www.frontiersin.org/articles/10.3389/fonc.2023.1212696/full |
| work_keys_str_mv | AT haichangli clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT yuninghu clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT dongninglu clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT jingyunwang clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT yanzelin clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT xugangzhong clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT yixuanmou clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT cenchaoyao clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT zhidawang clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT xinyuzhang clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT qijunwo clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT hanboliu clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT fengliu clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT dahongzhang clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy AT hengwang clinicalapplicationofsuperselectivetransarterialembolizationofrenaltumorsinzeroischaemiaroboticassistedlaparoscopicpartialnephrectomy |